Cargando…
PB1897: DISCONTINUATION OF IMATINIB IN PATIENTS FOLLOWED FOR CHRONIC MYELOID LEUKEMIA IN DEEP MOLECULAR RESPONSE
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429072/ http://dx.doi.org/10.1097/01.HS9.0000850440.38789.88 |
| _version_ | 1784779319542808576 |
|---|---|
| author | Bouchakor Moussa, Y. Taoussi, S. Oukid, S. Lamraoui, F. Rekab, N. Benlabiod, K. M. Brahimi, H. Abad, M. T. Bradai, M. |
| author_facet | Bouchakor Moussa, Y. Taoussi, S. Oukid, S. Lamraoui, F. Rekab, N. Benlabiod, K. M. Brahimi, H. Abad, M. T. Bradai, M. |
| author_sort | Bouchakor Moussa, Y. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429072 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94290722022-08-31 PB1897: DISCONTINUATION OF IMATINIB IN PATIENTS FOLLOWED FOR CHRONIC MYELOID LEUKEMIA IN DEEP MOLECULAR RESPONSE Bouchakor Moussa, Y. Taoussi, S. Oukid, S. Lamraoui, F. Rekab, N. Benlabiod, K. M. Brahimi, H. Abad, M. T. Bradai, M. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429072/ http://dx.doi.org/10.1097/01.HS9.0000850440.38789.88 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Bouchakor Moussa, Y. Taoussi, S. Oukid, S. Lamraoui, F. Rekab, N. Benlabiod, K. M. Brahimi, H. Abad, M. T. Bradai, M. PB1897: DISCONTINUATION OF IMATINIB IN PATIENTS FOLLOWED FOR CHRONIC MYELOID LEUKEMIA IN DEEP MOLECULAR RESPONSE |
| title | PB1897: DISCONTINUATION OF IMATINIB IN PATIENTS FOLLOWED FOR CHRONIC MYELOID LEUKEMIA IN DEEP MOLECULAR RESPONSE |
| title_full | PB1897: DISCONTINUATION OF IMATINIB IN PATIENTS FOLLOWED FOR CHRONIC MYELOID LEUKEMIA IN DEEP MOLECULAR RESPONSE |
| title_fullStr | PB1897: DISCONTINUATION OF IMATINIB IN PATIENTS FOLLOWED FOR CHRONIC MYELOID LEUKEMIA IN DEEP MOLECULAR RESPONSE |
| title_full_unstemmed | PB1897: DISCONTINUATION OF IMATINIB IN PATIENTS FOLLOWED FOR CHRONIC MYELOID LEUKEMIA IN DEEP MOLECULAR RESPONSE |
| title_short | PB1897: DISCONTINUATION OF IMATINIB IN PATIENTS FOLLOWED FOR CHRONIC MYELOID LEUKEMIA IN DEEP MOLECULAR RESPONSE |
| title_sort | pb1897: discontinuation of imatinib in patients followed for chronic myeloid leukemia in deep molecular response |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429072/ http://dx.doi.org/10.1097/01.HS9.0000850440.38789.88 |
| work_keys_str_mv | AT bouchakormoussay pb1897discontinuationofimatinibinpatientsfollowedforchronicmyeloidleukemiaindeepmolecularresponse AT taoussis pb1897discontinuationofimatinibinpatientsfollowedforchronicmyeloidleukemiaindeepmolecularresponse AT oukids pb1897discontinuationofimatinibinpatientsfollowedforchronicmyeloidleukemiaindeepmolecularresponse AT lamraouif pb1897discontinuationofimatinibinpatientsfollowedforchronicmyeloidleukemiaindeepmolecularresponse AT rekabn pb1897discontinuationofimatinibinpatientsfollowedforchronicmyeloidleukemiaindeepmolecularresponse AT benlabiodkm pb1897discontinuationofimatinibinpatientsfollowedforchronicmyeloidleukemiaindeepmolecularresponse AT brahimih pb1897discontinuationofimatinibinpatientsfollowedforchronicmyeloidleukemiaindeepmolecularresponse AT abadmt pb1897discontinuationofimatinibinpatientsfollowedforchronicmyeloidleukemiaindeepmolecularresponse AT bradaim pb1897discontinuationofimatinibinpatientsfollowedforchronicmyeloidleukemiaindeepmolecularresponse |